• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前眼科检查依从性与增生性糖尿病视网膜病变玻璃体切除术后视力结果的关系。

Relationship between compliance with ophthalmic examinations preoperatively and visual outcome after vitrectomy for proliferative diabetic retinopathy.

机构信息

Kyorin Eye Center, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.

出版信息

Jpn J Ophthalmol. 2012 Sep;56(5):481-7. doi: 10.1007/s10384-012-0161-4. Epub 2012 Jul 6.

DOI:10.1007/s10384-012-0161-4
PMID:22763797
Abstract

PURPOSE

To evaluate the relationship between compliance with ophthalmic examinations before vitrectomy for proliferative diabetic retinopathy (PDR) and postoperative vision.

METHODS

The clinical findings and visual acuity in 128 eyes of 94 patients who had undergone vitrectomy for PDR were reviewed. The patients were divided into the never-examined group with no previous ophthalmic examination until the first visit when vitrectomy was prescribed, the noncompliant group with a history of missing ophthalmic examinations over a 1-year period, and the compliant group with ophthalmic examinations at least once a year before the vitrectomy.

RESULTS

Compliance with general medical examinations in the never-examined group (19 %) and in the noncompliant group (26 %) was significantly lower than that in the compliant group (100 %; P < 0.001 and P < 0.001, respectively). The mean glycosylated hemoglobin in the never-examined group (8.9 %) was significantly higher than that in the compliant group (7.6 %; P = 0.047). The postoperative visual acuities at 6 months and at the final visit were significantly better in the compliant group than in the never-examined group (P = 0.017).

CONCLUSIONS

Compliance with preoperative examinations significantly affects vision after vitrectomy for PDR. Low compliance with ophthalmic examinations was significantly associated with low compliance with general medical examinations and high blood glucose levels.

摘要

目的

评估增殖型糖尿病性视网膜病变(PDR)患者行玻璃体切割术前眼部检查依从性与术后视力的关系。

方法

回顾性分析了 94 例(128 只眼)行玻璃体切割术治疗 PDR 患者的临床资料和视力。患者分为从未检查组(在接受玻璃体切割术治疗前,一直未进行眼科检查,直至首次就诊时才开始)、不依从组(在过去 1 年内错过眼科检查的次数超过 1 次)和依从组(在玻璃体切割术前每年至少进行 1 次眼科检查)。

结果

从未检查组(19%)和不依从组(26%)患者的一般医疗检查依从性显著低于依从组(100%;P<0.001 和 P<0.001)。从未检查组患者的平均糖化血红蛋白(8.9%)显著高于依从组(7.6%;P=0.047)。依从组患者术后 6 个月和最终随访时的视力显著优于从未检查组(P=0.017)。

结论

术前检查的依从性显著影响 PDR 患者玻璃体切割术后的视力。眼部检查依从性低与一般医疗检查依从性低和血糖水平高显著相关。

相似文献

1
Relationship between compliance with ophthalmic examinations preoperatively and visual outcome after vitrectomy for proliferative diabetic retinopathy.术前眼科检查依从性与增生性糖尿病视网膜病变玻璃体切除术后视力结果的关系。
Jpn J Ophthalmol. 2012 Sep;56(5):481-7. doi: 10.1007/s10384-012-0161-4. Epub 2012 Jul 6.
2
Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy.增生型糖尿病视网膜病变玻璃体中白细胞介素-8 和血管内皮生长因子水平与玻璃体切除术后视力的关系。
Acta Ophthalmol. 2010 Dec;88(8):e311-6. doi: 10.1111/j.1755-3768.2010.02030.x. Epub 2010 Nov 12.
3
Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.在玻璃体切除术治疗增生性糖尿病视网膜病变前玻璃体内注射贝伐单抗。
Eur J Ophthalmol. 2009 Sep-Oct;19(5):848-52. doi: 10.1177/112067210901900526.
4
Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变玻璃体切除术后与视力相关的生活质量和视觉功能
Am J Ophthalmol. 2008 Jun;145(6):1031-1036. doi: 10.1016/j.ajo.2008.02.006. Epub 2008 Apr 9.
5
Severe proliferative diabetic retinopathy treated with vitrectomy or panretinal photocoagulation: a monocenter randomized controlled clinical trial.玻璃体切除术或全视网膜光凝治疗严重增殖性糖尿病视网膜病变的单中心随机对照临床试验。
Can J Ophthalmol. 2011 Aug;46(4):345-51. doi: 10.1016/j.jcjo.2011.06.012. Epub 2011 Jul 7.
6
[Long-term results of vitrectomy for complications of proliferative diabetic retinopathy].[玻璃体切除术治疗增殖性糖尿病视网膜病变并发症的长期结果]
Nippon Ganka Gakkai Zasshi. 2001 Jul;105(7):457-62.
7
Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.增生性糖尿病视网膜病变患者行玻璃体切割术,术前单次玻璃体腔内注射或未注射贝伐单抗后的6个月视力转归
Int Ophthalmol. 2012 Apr;32(2):135-44. doi: 10.1007/s10792-012-9541-5. Epub 2012 Mar 27.
8
Clinical features of diabetic patients referred by general physicians due to less ophthalmic examinations.由于眼科检查较少,由普通内科医生转诊的糖尿病患者的临床特征。
Clin Ophthalmol. 2014 Jul 16;8:1331-5. doi: 10.2147/OPTH.S65707. eCollection 2014.
9
Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.玻璃体腔内注射贝伐单抗治疗严重增生性糖尿病视网膜病变的手术治疗。
Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3. Epub 2010 Feb 5.
10
[Vitrectomy for proliferative diabetic retinopathy].[增殖性糖尿病视网膜病变的玻璃体切除术]
Nippon Ganka Gakkai Zasshi. 2005 Mar;109(3):134-41.

引用本文的文献

1
Clinical features of diabetic patients referred by general physicians due to less ophthalmic examinations.由于眼科检查较少,由普通内科医生转诊的糖尿病患者的临床特征。
Clin Ophthalmol. 2014 Jul 16;8:1331-5. doi: 10.2147/OPTH.S65707. eCollection 2014.
2
Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.玻璃体切除术后玻璃体腔内注射贝伐单抗治疗持续性糖尿病性黄斑水肿后的视力相关生活质量和视觉功能
Jpn J Ophthalmol. 2014 Jul;58(4):369-74. doi: 10.1007/s10384-014-0323-7. Epub 2014 Apr 29.

本文引用的文献

1
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.强化血糖控制对 2 型糖尿病患者微血管结局的影响:ACCORD 随机试验分析。
Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30.
2
Standards of medical care in diabetes--2009.《糖尿病医疗护理标准——2009》
Diabetes Care. 2009 Jan;32 Suppl 1(Suppl 1):S13-61. doi: 10.2337/dc09-S013.
3
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.
威斯康星糖尿病视网膜病变流行病学研究:XXII 1型糖尿病患者视网膜病变的25年进展情况
Ophthalmology. 2008 Nov;115(11):1859-68. doi: 10.1016/j.ophtha.2008.08.023.
4
Overview of epidemiologic studies of diabetic retinopathy.糖尿病视网膜病变的流行病学研究综述。
Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):179-83. doi: 10.1080/09286580701396720.
5
Duration of diabetes and screening coverage for retinopathy among patients with type 2 diabetes.2型糖尿病患者的糖尿病病程及视网膜病变筛查覆盖率
Ophthalmic Epidemiol. 2007 Mar-Apr;14(2):76-9. doi: 10.1080/09286580600879032.
6
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗增殖性糖尿病视网膜病变。
Ophthalmology. 2006 Oct;113(10):1695.e1-15. doi: 10.1016/j.ophtha.2006.05.064.
7
Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy.玻璃体内注射贝伐单抗(阿瓦斯汀)作为增殖性糖尿病视网膜病变的辅助治疗。
Am J Ophthalmol. 2006 Oct;142(4):685-8. doi: 10.1016/j.ajo.2006.04.058.
8
Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study.2型糖尿病拉丁裔患者视力保健指南的不依从性:洛杉矶拉丁裔眼病研究
Ophthalmology. 2006 Aug;113(8):1372-7. doi: 10.1016/j.ophtha.2006.04.018. Epub 2006 Jun 12.
9
Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study.1型糖尿病发病队列在前4至14年随访期间视网膜病变的患病率和严重程度低于预期:威斯康星糖尿病登记研究
Am J Epidemiol. 2006 Jul 15;164(2):143-50. doi: 10.1093/aje/kwj166. Epub 2006 May 26.
10
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.激光光凝治疗糖尿病视网膜病变患者的长期效果:早期治疗糖尿病视网膜病变随访研究
Ophthalmology. 2003 Sep;110(9):1683-9. doi: 10.1016/S0161-6420(03)00579-7.